Image For Activity Cover
Session 1–Update on PE: Latest Data, Guidance, Emerging Trials. Session 2–Emerging Technology in PVI
How to Register
  1. To register, press the "Login or Register" button.
  2. Sign in with your scai.org username and password. If you don't have an account, click “Set Up Your Login.”
  3. Once registered, you will see a screen where you can add the webinar to your calendar.
All registrants receive access to the webinar recording.
Thursday, July 24
Update on Pulmonary Embolism: Latest Data and Guidance and Emerging Trials
Eastern Time 6 - 7:00 pm
Central Time 5 - 6:00 pm
Mountain Time 4 - 5:00 pm
Pacific Time 3 - 4:00 pm

The Future is Upon Us: Emerging Technology and PVI
Eastern Time 7 - 8:15 pm
Central Time 6 - 7:15 pm
Mountain Time 5 - 6:15 pm
Pacific Time 4 - 5:15 pm
Update on Pulmonary Embolism: Latest Data and Guidance and Emerging Trials

Moderators : Kenneth Rosenfield, MD, MSCAI and Victor Tapson, MD 

•    Introduction, Kenneth Rosenfield, MD, MSCAI 
•    Acute PE Disease, Victor Tapson, MD 
•    Risk Stratification and Options for Treatment in Intermediate-Risk PE, Gregory Piazza, MD, MS 
•    Management Decisions and Role of PERT, Kenneth Rosenfield, MD, MSCAI 
•    Case Discussion         
•    HI-PEITHO: A Landmark Randomized Trial! Design and Goals, Stavros Konstantinides, MD, PhD, FESC 
•    Panel Discussion, Q&A    

Learning Objectives
After completing this webinar, participants should be able to:

  1. Describe the symptoms of acute pulmonary embolism (PE) disease.
  2. Discuss risk stratification and options for treatment in intermediate-risk PE.
  3. Summarize the role of the pulmonary embolism response team (PERT).     
  4. Analyze the designs and goals of the HI-PEITHO randomized trial.

Acknowledgment of Commercial Support

This activity was supported by an unrestricted educational grant from Boston Scientific. No in-kind commercial support was received.

Continuing Education Information

Accreditation Statement

The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the 
Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

​Credit Designation
SCAI designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

​ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Successful Completion
Watch the content and complete the evaluation to obtain credit.

The Future is Upon Us: Emerging Technology and PVI
Agenda & Invited Faculty

This webinar will review the newest technology in peripheral intervention either currently available or coming to market. Experts in the field will discuss the data surrounding these devices, the anticipated impact on clinical care, and future directions in the field of peripheral vascular interventions.

Moderator: Sasanka Jayasuriya, MD, FSCAI 
Q&A Moderator: Faisal Latif, MD, FSCAI 

•    What's New in Vascular Scaffolds?, Peter Monteleone, MD, FSCAI
•    Seeing Is Believing: From IVUS to OCT to FORS, Joseph Campbell, MD, FSCAI
•    Atherectomy, Lithotripsy, Thrombectomy, and More, Santhosh Jay Mathews, MD, FSCAI
•    Addressing the Unaddressed: PQ Bypass and Deep Vein Arterialization for Limb Salvage, Fadi A. Saab, MD, FSCAI
•    Round 2: Is Renal Denervation Here to Stay?, David E. Kandzari, MD, FSCAI

Learning Objectives

After completing this webinar, participants should be able to:

  1. Discuss data for new scaffolds being designed for arterial and venous vascular beds.
  2. Describe the data supporting intravascular imaging to guide peripheral intervention.     
  3. Give examples of clinical scenarios where new thrombectomy and atherectomy devices can make an impact.
  4. Compare the current approach to endovascular bypass techniques versus future trials and studies supporting expansion of these approaches.
  5. Examine the recent and upcoming trials of new renal denervation devices and likely target populations most likely to benefit.

Continuing Education Information

Accreditation Statement
The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the 
Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

​Credit Designation
SCAI designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

​ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.25 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Successful Completion
Watch the content and complete the evaluation to obtain credit.

Copyright
© 2021-2022 Society for Cardiovascular Angiography and Interventions (SCAI). All rights reserved.
Summary
Availability: Retired
Cost: FREE
Credit Offered:
No Credit Offered
Contains: 5 Courses
Powered By